Search

everythinglearnresearchcommunity

for

Search:↓

High mTORC1 activity slows hair growth and causes it to lose color.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

CBD may improve skin and hair health, but its effective use and safety need more research.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Nanocarriers make melatonin more effective and reduce side effects.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

The document concludes that significant investment in agricultural innovation is necessary to achieve global food security and nutrition.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Long COVID patients have more health issues than non-infected people.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Liposomes and niosomes can help drugs penetrate the skin better.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Optimizing drug delivery to hair follicles is crucial for effective treatment.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Lipid nanoparticles can help deliver drugs through hair follicles but struggle to penetrate deeper skin layers.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Drugs can be incorporated into hair based on their chemical properties and hair pigmentation.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced human skin models improve drug development and could replace animal testing.

Keratin films from human hair can potentially replace human nail plates for drug testing.